Key Financial Viability Considerations for Laboratorians Considering Bringing Clinical Pharmacogenomics Testing into the Laboratory

Learn essential financial strategies for implementing clinical pharmacogenomics (PGx) testing in laboratory settings through this 58-minute webinar presented by Dr. Becky Winslow, PharmD, founder of inGENEious RX Inc. Discover how laboratories can leverage existing COVID testing equipment to perform PGx testing while maximizing financial viability and sustainability. Explore critical considerations for PGx test panel design and utilization that align with payers' medical necessity definitions and existing coverage guidelines. Examine current payer recognition of clinical pharmacogenomic testing with sufficient clinical utility evidence, including coverage and reimbursement policies for drug metabolizing enzyme gene variants, drug transporter gene variants, and gene variants predisposing patients to adverse events and affecting drug efficacy. Gain insights into optimizing laboratory operations based on established billing and coding guidelines for pharmacogenetic associations. Participate in live Q&A sessions to address specific implementation challenges and receive expert guidance on transitioning from COVID testing to sustainable PGx testing services. Earn PACE credits upon completion through Labroots' certification program, with credits valid until November 13, 2026.